168 related articles for article (PubMed ID: 27357932)
21. Stability of placental growth factor, soluble fms-like tyrosine kinase 1, and soluble fms-like tyrosine kinase 1 e15a in human serum and plasma.
Rowson S; Reddy M; Rolnik DL; Da Silva Costa F; Palmer KR
Placenta; 2019 Oct; 86():1-3. PubMed ID: 31476387
[TBL] [Abstract][Full Text] [Related]
22. Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks' pregnancy in normotensive women.
Wataganara T; Pratumvinit B; Lahfahroengron P; Pooliam J; Talungchit P; Leetheeragul J; Sukpanichnant S
J Perinat Med; 2017 Oct; 45(7):895-901. PubMed ID: 28665791
[TBL] [Abstract][Full Text] [Related]
23. Angiogenic markers during preeclampsia: Are they associated with hypertension 1 year postpartum?
Neuman RI; Figaroa AMJ; Nieboer D; Saleh L; Verdonk K; Danser AHJ; Duvekot HJJ; van den Meiracker AH; Roeters van Lennep J; Visser W
Pregnancy Hypertens; 2021 Mar; 23():116-122. PubMed ID: 33321329
[TBL] [Abstract][Full Text] [Related]
24. Verification of placental growth factor and soluble-fms-like tyrosine kinase 1 assay performance in late pregnancy and their diagnostic test accuracy in women with reduced fetal movement.
Armstrong-Buisseret LK; Haslam S; James T; Bradshaw L; Heazell AE
Ann Clin Biochem; 2020 May; 57(3):223-233. PubMed ID: 32081030
[TBL] [Abstract][Full Text] [Related]
25. Prediction of adverse perinatal outcome by serum placental growth factor and soluble fms-like tyrosine kinase-1 in women undergoing induction of labor.
Fiolna M; Machuca M; Karampitsakos T; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 Nov; 54(5):604-608. PubMed ID: 31444934
[TBL] [Abstract][Full Text] [Related]
26. Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction.
Hochholzer W; Reichlin T; Stelzig C; Hochholzer K; Meissner J; Breidthardt T; Reiter M; Duehsler B; Freidank H; Winkler K; Twerenbold R; Mueller C
Eur Heart J; 2011 Feb; 32(3):326-35. PubMed ID: 21138939
[TBL] [Abstract][Full Text] [Related]
27. Copeptin and mid-regional pro-atrial natriuretic peptide in women with suspected or confirmed pre-eclampsia: comparison with sFlt-1/PlGF ratio.
Neuman RI; van der Meer MMA; Saleh L; van den Berg SAA; van den Meiracker AH; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2020 Dec; 56(6):872-878. PubMed ID: 31975510
[TBL] [Abstract][Full Text] [Related]
28. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
[TBL] [Abstract][Full Text] [Related]
29. Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation.
Tal R; Seifer DB; Grazi RV; Malter HE
Reprod Biol Endocrinol; 2014 Aug; 12():82. PubMed ID: 25141961
[TBL] [Abstract][Full Text] [Related]
30. Angiogenic factors during pregnancy in Asian women with elevated blood pressure in early pregnancy and the risk of preeclampsia: a longitudinal cohort study.
Zhu J; Zhang J; Ng MJ; Chern B; Yeo GS; Tan KH
BMJ Open; 2019 Dec; 9(11):e032237. PubMed ID: 31791965
[TBL] [Abstract][Full Text] [Related]
31. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
Andersen LB; Dechend R; Jørgensen JS; Luef BM; Nielsen J; Barington T; Christesen HT
Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383
[TBL] [Abstract][Full Text] [Related]
32. Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio: A Prospective Cohort Study of Unselected Nulliparous Women.
Sovio U; Gaccioli F; Cook E; Hund M; Charnock-Jones DS; Smith GC
Hypertension; 2017 Apr; 69(4):731-738. PubMed ID: 28167687
[TBL] [Abstract][Full Text] [Related]
33. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
Jääskeläinen T; Heinonen S; Hämäläinen E; Pulkki K; Romppanen J; Laivuori H;
Pregnancy Hypertens; 2018 Oct; 14():252-259. PubMed ID: 29803331
[TBL] [Abstract][Full Text] [Related]
34. Can placental growth factors explain birthweight variation in offspring of women with type 1 diabetes?
Bacon S; Burger D; Tailor M; Sanchez JJ; Tomlinson G; Murphy HR; Feig DS;
Diabetologia; 2021 Jul; 64(7):1527-1537. PubMed ID: 33839801
[TBL] [Abstract][Full Text] [Related]
35. Circulating angiogenic factors and the risk of preeclampsia.
Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
[TBL] [Abstract][Full Text] [Related]
36. Circulating angiogenic factors and placental abruption.
Signore C; Mills JL; Qian C; Yu K; Lam C; Epstein FH; Karumanchi SA; Levine RJ
Obstet Gynecol; 2006 Aug; 108(2):338-44. PubMed ID: 16880304
[TBL] [Abstract][Full Text] [Related]
37. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.
Graupner O; Karge A; Flechsenhar S; Seiler A; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B
Arch Gynecol Obstet; 2020 Feb; 301(2):375-385. PubMed ID: 31734756
[TBL] [Abstract][Full Text] [Related]
38. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
[TBL] [Abstract][Full Text] [Related]
39. Associations Between Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia.
Hastie R; Bergman L; Walker SP; Kaitu'u-Lino T; Hannan NJ; Brownfoot F; Schell S; Harper A; Cannon P; Cluver CA; Tong S
J Am Heart Assoc; 2022 Aug; 11(16):e024395. PubMed ID: 35943054
[TBL] [Abstract][Full Text] [Related]
40. The effect of nicotine-containing products and fetal sex on placenta-associated circulating midpregnancy biomarkers.
Sundet BK; Kreyberg I; Staff AC; Carlsen KCL; Bains KES; Berg JP; Granum B; Haugen G; Hedlin G; Jonassen CM; Nordhagen LS; Nordlund B; Rehbinder EM; Rudi K; Rueegg CS; Sjøborg KD; Skjerven HO; Söderhäll C; Vettukattil R; Sugulle M
Biol Sex Differ; 2022 Jul; 13(1):39. PubMed ID: 35841068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
